Unknown

Dataset Information

TLR4 antagonism provides short-term but not long-term clinical benefit in a full-depth cartilage defect mouse model.


ABSTRACT:

Purpose/aim

Cartilage injury and subsequent osteoarthritis (OA) are debilitating conditions affecting millions worldwide. As there are no cures for these ailments, novel therapies are needed to suppress disease pathogenesis. Given that joint injuries are known to produce damage-associated molecular patterns (DAMPs), our central premise is that the Toll-like receptor 4 (TLR4) pathway is a principal driver in the early response to cartilage damage and subsequent pathology. We postulate that TLR4 activation is initiated/perpetuated by DAMPs released following joint damage. Thus, antagonism of the TLR4 pathway immediately after injury may suppress the development of joint surface defects.

Materials and methods

Two groups were utilized: (1) 8-week-old, male C57BL6 mice treated sy

SUBMITTER: Timkovich AE 

PROVIDER: S-EPMC11271750 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature